Dr. Rana M. Abdel Naby, Lecturer of Pharmaceutical Chemistry

Dr. Rana M. Abdel Naby is a Lecturer of Pharmaceutical Chemistry at the Faculty of Pharmacy and Drug Technology at Heliopolis University for Sustainable Development. She earned her bachelor’s degree with distinction in 2003 at Ain Shams University, her master’s degree in 2012 at the same university, and her PhD in 2016 at Cairo University. Her doctoral thesis titled “Design, synthesis, and biological evaluation of novel coumarin derivatives as potential anti-tumor agents”

She started her career as a Teaching Assistant in 2004. She was promoted to an Assistant Lecturer in 2012 and in 2016 to a Lecturer at Misr University for Science and Technology. In September 2017, she moved to Heliopolis University for Sustainable Development to be a Lecturer of Pharmaceutical Chemistry and Drug Design. She is also a member of the Committee of Ethics for Scientific Research and the Quality Assurance Unit at the university.

Dr. Abdel-Naby’s research interests include:

• Computer aided development of novel tyrosine kinase inhibitors having coumarin as the main nucleus.
• Computer-based molecular design and synthesis of certain thienopyrimidines attached to arylpiperazine moiety having potential antihypertensive activity.
• Design, synthesis, and biological evaluation of novel coumarin derivatives as potential anti-tumor agents.

Dr. Abdel Naby is a Certified International Professional Trainer (CIPT) accredited by Cairo University and University of Missouri. She has many scholarly publications that include:

1- Dalal A. Abou El-Ella, Mohammed M. Hussein, Rabah A. T. Serya, Rana M. Abdel Naby, Ahmed M. Al-Abd, Dalia O. Saleh, Wafaa I. El-Eraky and Khaled A. M. Abouzid. “Molecular Modeling and Synthesis of 1, 4-disubstitited Piperazines as α1-adrenergic Receptor Blockers” Bioorg Chem 54, P. 21-30, 2014.

2- Kamilia M. Amin, Sahar M. Abou-seri, Rana M. Abdelnaby, Heba S. Rateb, Mahmoud A. F. Khalil, Mohamed M. Hussein “Synthesis and biological evaluation of novel coumarin derivatives as potential antimicrobial agents”. Int J. Pharm. Pharm. Sci. 4, P. 109-116, 2016.